Market Place
Sourcing Support
EMA Accepts Marketing Application for AVT05 Biosimilar to Simponi®
04 Nov 2024 //
GLOBENEWSWIRE
Bio-Thera, STADA: Golimumab Biosimilar EU, UK Agreement For BAT2506
28 May 2024 //
PR NEWSWIRE
Alvotech`s AVT05 Simponi® Biosimilar Topline Results
24 Apr 2024 //
GLOBENEWSWIRE
Centocor`s Biologic Simponi (golimumab) Receives Approval in the U.S.
16 Nov 2023 //
FDA
Centocor`s Biologic Simponi (Golimumab) Receives Approval in the U.S.
30 Mar 2023 //
FDA
J&J Ulcerative Colitis Clinical Trial Produces High Rate of Remission
13 Oct 2022 //
PHARMANEWSINTEL
Study of Guselkumab & Golimumab Therapy Show Higher Rates of Clinical Remission
10 Oct 2022 //
PRNEWSWIRE
Lupin, DKSH enter pact to commercials Alvotech biosimilars in Philippines
07 Sep 2022 //
ECONOMIC TIMES
Lupin and DKSH sign exclusive licensing and supply agreement to market five
06 Sep 2022 //
EXPRESS PHARMA
Results of Novel Study Show Adults with UC Achieved Higher Response Rates
19 Feb 2022 //
PRNEWSWIRE
Bio-Thera Solutions Initiates Phase III Clinical Trial for BAT2506
08 Jun 2021 //
BUSINESSWIRE
Bio-Thera Solutions Initiates Phase III Clinical Trial for BAT2506
08 Jun 2021 //
BUSINESSWIRE
US FDA approves Janssen’s Simponi Aria to treat polyarticular juvenile
02 Oct 2020 //
PHARMABIZ
SIMPONI ARIA®Approved by the USFDAfor Active Polyarticular JuvenileIA
30 Sep 2020 //
PRNEWSWIRE
Janssen Biotech`s Biological Golimumab Receives Approval In US
29 Sep 2020 //
FDA
ICER criticizes cost of 8 targeted immune modulators for UC
15 Sep 2020 //
ENDPOINTS
Retrospective Real-World Comparative Analysis Highlights Safety of Vedolizumab
21 Oct 2019 //
BUSINESSWIRE
Bio-Thera Solutions Initiates Ph I Clinical Trial for BAT2506, Simponi®
14 Aug 2019 //
BUSINESSWIRE
Celsius Therapeutics inks first biopharma deal—an IBD study with Janssen
10 Jul 2019 //
FIERCE BIOTECH
Janssen Doubles Down on Bioinformatics with Celsius Therapeutics Partnership
09 Jul 2019 //
BIOSPACE
Meeting highlights from the CHMP 10-13 December 2018
14 Dec 2018 //
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.